Literature DB >> 3370836

Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland.

J J Series1, E M Biggart, D S O'Reilly, C J Packard, J Shepherd.   

Abstract

As part of a screening programme for coronary heart disease risk factors, fasting plasma cholesterol was measured in 2,250 people from the east-end of Glasgow. Plasma thyrotropin (TSH) was measured in the 90 individuals (4% of the population studied) who had a cholesterol level greater than or equal to 8.0 mmol/l. Four had unequivocal biochemical evidence of hypothyroidism-TSH greater than 34 mU/l and a low plasma thyroxine (T4) less than or equal to 45 nmol/l. A further 8 were found to have raised TSH levels suggesting they may have subclinical hypothyroidism. These data indicate that thyroid dysfunction may make a significant contribution to hypercholesterolaemia in the general population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370836     DOI: 10.1016/0009-8981(88)90326-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  Testing pitfalls and summary of guidance in lipid management.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2006-07-08

Review 2.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.

Authors:  A F Winder; C Jagger; D P Garrick; D T Vallance; P F Butowski; J Anderson; M Clarke
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

4.  Hyperlipidaemia and hypothyroidism. Screening everyone would be expensive and unnecessary.

Authors:  A Waise
Journal:  BMJ       Date:  1994-04-02

5.  Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations.

Authors:  D Rubello; G B Pozzan; D Casara; M E Girelli; S Boccato; F Rigon; C Baccichetti; M Piccolo; C Betterle; B Busnardo
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

6.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

7.  Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats.

Authors:  T G Redgrave; C L Elsegood; J C Mamo; M J Callow
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

8.  Asymptomatic hypothyroidism and hypercholesterolaemia.

Authors:  M J Ball; D Griffiths; M Thorogood
Journal:  J R Soc Med       Date:  1991-09       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.